vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and HEALTHCARE SERVICES GROUP INC (HCSG). Click either name above to swap in a different company.

Genius Sports Ltd is the larger business by last-quarter revenue ($510.9M vs $466.7M, roughly 1.1× HEALTHCARE SERVICES GROUP INC). Genius Sports Ltd produced more free cash flow last quarter ($69.6M vs $16.0M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 5.0%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.

GENI vs HCSG — Head-to-Head

Bigger by revenue
GENI
GENI
1.1× larger
GENI
$510.9M
$466.7M
HCSG
More free cash flow
GENI
GENI
$53.6M more FCF
GENI
$69.6M
$16.0M
HCSG
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
5.0%
HCSG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GENI
GENI
HCSG
HCSG
Revenue
$510.9M
$466.7M
Net Profit
$-63.0M
Gross Margin
25.2%
15.4%
Operating Margin
-11.5%
6.1%
Net Margin
-12.3%
Revenue YoY
6.6%
Net Profit YoY
EPS (diluted)
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
HCSG
HCSG
Q4 25
$510.9M
$466.7M
Q3 25
$335.4M
$464.3M
Q2 25
$215.2M
$458.5M
Q1 25
$119.7M
$447.7M
Q4 24
$413.0M
$437.8M
Q3 24
$285.8M
$428.1M
Q2 24
$184.1M
$426.3M
Q1 24
$97.2M
$423.4M
Net Profit
GENI
GENI
HCSG
HCSG
Q4 25
$-63.0M
Q3 25
$43.0M
Q2 25
$-47.3M
$-32.4M
Q1 25
$-25.5M
$17.2M
Q4 24
$-85.5M
Q3 24
$-47.1M
$14.0M
Q2 24
$-35.5M
$-1.8M
Q1 24
$-25.2M
$15.3M
Gross Margin
GENI
GENI
HCSG
HCSG
Q4 25
25.2%
15.4%
Q3 25
24.2%
20.8%
Q2 25
19.1%
0.6%
Q1 25
10.7%
15.2%
Q4 24
16.7%
13.4%
Q3 24
20.5%
14.8%
Q2 24
18.6%
9.7%
Q1 24
9.8%
15.2%
Operating Margin
GENI
GENI
HCSG
HCSG
Q4 25
-11.5%
6.1%
Q3 25
-15.3%
12.3%
Q2 25
-21.0%
-9.1%
Q1 25
-20.3%
5.3%
Q4 24
-18.0%
3.4%
Q3 24
-13.9%
4.4%
Q2 24
-16.8%
-0.5%
Q1 24
-23.7%
5.0%
Net Margin
GENI
GENI
HCSG
HCSG
Q4 25
-12.3%
Q3 25
9.3%
Q2 25
-22.0%
-7.1%
Q1 25
-21.3%
3.8%
Q4 24
-20.7%
Q3 24
-16.5%
3.3%
Q2 24
-19.3%
-0.4%
Q1 24
-25.9%
3.6%
EPS (diluted)
GENI
GENI
HCSG
HCSG
Q4 25
$0.43
Q3 25
$0.59
Q2 25
$-0.44
Q1 25
$0.23
Q4 24
$0.15
Q3 24
$0.19
Q2 24
$-0.02
Q1 24
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
HCSG
HCSG
Cash + ST InvestmentsLiquidity on hand
$280.6M
$168.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$724.5M
$510.2M
Total Assets
$1.1B
$794.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
HCSG
HCSG
Q4 25
$280.6M
$168.0M
Q3 25
$110.2M
$177.5M
Q2 25
$110.2M
$134.5M
Q1 25
$110.2M
$114.8M
Q4 24
$100.3M
$107.3M
Q3 24
$100.3M
$103.8M
Q2 24
$100.3M
$105.6M
Q1 24
$100.3M
$104.9M
Stockholders' Equity
GENI
GENI
HCSG
HCSG
Q4 25
$724.5M
$510.2M
Q3 25
$572.4M
$496.0M
Q2 25
$572.4M
$477.0M
Q1 25
$572.4M
$514.2M
Q4 24
$573.0M
$499.9M
Q3 24
$573.0M
$488.7M
Q2 24
$573.0M
$471.4M
Q1 24
$573.0M
$474.6M
Total Assets
GENI
GENI
HCSG
HCSG
Q4 25
$1.1B
$794.3M
Q3 25
$792.3M
$804.3M
Q2 25
$792.3M
$802.2M
Q1 25
$792.3M
$823.0M
Q4 24
$775.7M
$802.8M
Q3 24
$775.7M
$805.8M
Q2 24
$775.7M
$799.7M
Q1 24
$775.7M
$803.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
HCSG
HCSG
Operating Cash FlowLast quarter
$81.9M
$17.4M
Free Cash FlowOCF − Capex
$69.6M
$16.0M
FCF MarginFCF / Revenue
13.6%
3.4%
Capex IntensityCapex / Revenue
2.4%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$33.5M
$139.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
HCSG
HCSG
Q4 25
$81.9M
$17.4M
Q3 25
$-4.8M
$71.3M
Q2 25
$-1.2M
$28.8M
Q1 25
$-14.6M
$27.5M
Q4 24
$14.9M
$36.2M
Q3 24
$-9.2M
$4.3M
Q2 24
$16.3M
Q1 24
$-26.0M
Free Cash Flow
GENI
GENI
HCSG
HCSG
Q4 25
$69.6M
$16.0M
Q3 25
$-14.2M
$70.0M
Q2 25
$-5.8M
$27.4M
Q1 25
$-16.0M
$25.8M
Q4 24
$11.3M
$34.8M
Q3 24
$-11.6M
$2.9M
Q2 24
$15.0M
Q1 24
$-28.2M
FCF Margin
GENI
GENI
HCSG
HCSG
Q4 25
13.6%
3.4%
Q3 25
-4.2%
15.1%
Q2 25
-2.7%
6.0%
Q1 25
-13.4%
5.8%
Q4 24
2.7%
7.9%
Q3 24
-4.1%
0.7%
Q2 24
3.5%
Q1 24
-6.7%
Capex Intensity
GENI
GENI
HCSG
HCSG
Q4 25
2.4%
0.3%
Q3 25
2.8%
0.3%
Q2 25
2.1%
0.3%
Q1 25
1.2%
0.4%
Q4 24
0.9%
0.3%
Q3 24
0.9%
0.3%
Q2 24
0.3%
Q1 24
0.5%
Cash Conversion
GENI
GENI
HCSG
HCSG
Q4 25
Q3 25
1.66×
Q2 25
Q1 25
1.60×
Q4 24
Q3 24
0.31×
Q2 24
Q1 24
-1.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GENI
GENI

Segment breakdown not available.

HCSG
HCSG

Dietary Services$255.9M55%
Other$210.8M45%

Related Comparisons